Tuesday, April 30, 2024
HomePharma

Pharma

Pharma

Therini Bio Initiates First-In-Human Dosing in Phase 1 Trial of THN391, a Fibrin-Targeting Therapeutic Candidate for Alzheimer’s Disease

Life Sciences Times - 0
Pharma

InterVenn Demonstrates Power of Its GlycoVision™ Platform In Advanced Adenoma and Colorectal Cancer

Life Sciences Times - 0
Pharma

Almirall: Up to 73% of Atopic Dermatitis Patients Taking Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysis

Life Sciences Times - 0
Pharma

CinRx Pharma Announces First Participant Dosed in CinDome’s Phase 2 Study of Deudomperidone (CIN-102) for the Treatment of Diabetic Gastroparesis

Life Sciences Times - 0
Pharma

Alentis Therapeutics Reports Positive Topline Results From Phase 1 Multiple-ascending Dose Cohorts Study

Life Sciences Times - 0
Pharma

Virpax Reports on Progress of Envelta™

Life Sciences Times - 0
Pharma

AmbioPharm To Utilize YMC Twin-Column Chromatography in Large Scale Peptide Production

Life Sciences Times - 0
Pharma

Alzamend Neuro Announces Completion of Clinical Portion of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

Life Sciences Times - 0
Pharma

Kite’s Yescarta® CAR T-cell Therapy Demonstrates a Statistically Significant Improvement in Overall Survival for Initial Treatment of Relapsed/Refractory Large B-cell Lymphoma

Life Sciences Times - 0
Pharma

Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

Life Sciences Times - 0
Pharma

The Access to Advanced Health Institute Reports Encouraging Results of First-In-Human Trial of Its Temperature-Stable Tuberculosis Vaccine Candidate

Life Sciences Times - 0
Pharma

Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED® (ephedrine sulfate injection) Pre-Filled Syringe

Life Sciences Times - 0
1...567...56Page 6 of 56

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv